Life Sciences

Diagnostic company Oxford Immunotec of Marlborough, which also holds offices in Oxford, United Kingdom, will provide T-cell testing to the UK Vaccines Taskforce, a group formed by the government to assess vaccine suitability for the country’s residents.

Redevelopment of the former Worcester State Hospital is taking major steps forward with site work for two new life sciences buildings. The new development, though, won't include the century-old Hale Building, a last remnant of the old state hospital off Belmont Street.

Houston real estate development and management company McCord has its sights set on the MetroWest life sciences market with a recently acquired Northborough industrial building.

A biotechnology arm of the UMass Medical School has signed an agreement with a New Jersey pharmaceutical company to make investigational new drugs and commercial pharmaceutical products.

Webster developer Galaxy Life Sciences believes the Massachusetts life sciences industry is so strong, the company will have a new tenant lined up for its new $50-million biomanufacturing facility in a matter of months.

The ribbon has been cut at a new manufacturing facility in Hopkinton where Lykan Bioscience is anticipated to create 125 new jobs.

Cytiva, the rebranded GE Healthcare Life Sciences, is planning a new site in Shrewsbury as part of a worldwide expansion that includes roughly 200 additional jobs in Massachusetts.

Medical technology company Hologic, headquartered in Marlborough, announced Wednesday it has acquired Acessa Health Inc. for approximately $80 million in cash plus contingent payments based on future revenue growth.

A Boston life sciences development firm has bought its second and third sites in Devens this year, including two in a deal closed in July for $4.7 million.

Founded while CEO Tom Galati was still in college, the company, which has offices in Maryland, works with clients to help bring their drugs and therapeutics to the marketplace through pre-clinical and clinical research.